Zobrazeno 1 - 4
of 4
pro vyhledávání: '"David Leffel"'
Autor:
Mohammad Athar, Levy Kopelovich, James A. Crowell, Brittney-Shea Herbert, Allen E. Bale, Amruta Phatak, David Leffel
Publikováno v:
Oncotarget
// Amruta Phatak 1 , Mohammad Athar 2 , James A. Crowell 3 , David Leffel 4 , Brittney-Shea Herbert 1 , Allen E. Bale 5 and Levy Kopelovich 6 1 Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA
Autor:
David P. Kelsen, David Pfister, Farid Fata, David H. Ilson, Ephraim S. Casper, David Leffel, Eileen O'Reilly, Gary K. Schwartz
Publikováno v:
Cancer. 86:2034-2037
BACKGROUND Angiosarcomas are rare tumors. Based on a complete response observed in a patient with angiosarcoma of the scalp treated with paclitaxel in a Phase II trial, the authors treated a cohort of patients with angiosarcoma of the scalp or face w
Autor:
Michael J. Auletta, Ronald G. Duff, Michael Sabolinski, David Leffel, James E.C. Norris, Jessica L. Fewkes, Gary S. Rogers, Isabelle Thomas, Oscar M. Alvarez, Janet Hardin-Young, Manuel Irondo, John A. Zitelli, William H. Eaglstein
Publikováno v:
Dermatologic Surgery. 25:195-201
Background. Tissue-engineered products are usually composed of living cells and their supporting matrices that have been grown in vitro, using a combination of engineering and life sciences principles. Apligraf is a bilayered product composed of neon
Autor:
Mariam Totonchy, David Leffell
Publikováno v:
F1000Research, Vol 6 (2017)
Basal cell carcinoma (BCC) is the most common malignancy worldwide, arising from non-keratinizing cells within the basal layer of the epidermis. The incidence of BCC continues to rise annually, increasing the burden of management of these carcinomas
Externí odkaz:
https://doaj.org/article/d1c2d4b1e6814212bb30b67fddce89c4